It’s most common in two age groups: children from ... choose the right treatment. Chest X-ray. This can show whether your lungs are damaged, a possible sign of dermatomyositis.

Dermatomyositis is a rare ... Together, we can ensure early diagnosis and treatment for JDM, improving the quality of life for affected children. Read more news like this on HindustanTimes.com ...

The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical ...

It can affect anyone, but it's more common in adults aged 40 to 60 and children aged ... often get better with treatment. But while taking these medications, it's important to be careful to avoid ...

The Division of Pediatric Rheumatology at the University of Alabama at Birmingham/Children's Hospital of Alabama was created in the summer of 2007 in response to a great need for pediatric rheumatic ...

The U.S. Food and Drug Administration has approved Journey Medical's Emrosi (minocycline hydrochloride) for the treatment of ...

Actuate Therapeutics said its treatment for Ewing sarcoma was granted rare pediatric-disease designation from the Food and Drug Administration. Chief Executive Daniel Schmitt said early clinical data ...

Children require specialized care and a great deal of patience, given that many of them may find medical treatment intimidating. Seeing children in physical or psychological distress can also be ...

Company expects to commence Phase 3 trial of Descartes-08 in patients with myasthenia gravis in 1H2025 following recent meeting with U.S. Food ...

“Receiving rare pediatric disease designation from the FDA underscores the urgent need for new treatment options for patients with EWS and recognizes elraglusib’s transformative potential,” said ...

“JIA can take a heavy toll on the lives of affected children and families,” said Daniel Horton, a faculty member at the ...